Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Thursday, February 6, 2025, at 9:00 a.m. ET, to discuss its 2024 Fourth-Quarter and Full-Year financial results,

The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical products, authorized, on 16

Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris International, which faced years long decline in cigarette smoking. The FDA earlier this month authorized 20 Zyn products to be marketed and sold on the U.

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.

FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some questions linger. Experts explain the efficacy and potential health risks of nicot

The news is particularly relevant for British American Tobacco, which, along with its industry peers, can now potentially avoid the financial impact that a menthol ban would have had on their sales and market share. This regulatory reprieve has provided a boost to their stocks as the market opens this week.

While technology stocks get a lot of attention from the media, there are a lot of attractive options in the consumer goods space as well. While often classified as a consumer goods stock, Amazon (NASDAQ: AMZN) is really a combination of a consumer goods company and a technology company.

The Food and Drug Administration has ignited a heated debate with its latest review of menthol cigarettes, revealing concerning patterns that could lead to

Publicly traded companies in the space include Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM). Published first on TheFly – the ultimate source ...

Philip Morris (PM) has received a new Buy rating, initiated by Morgan Stanley analyst, Eric Serotta.Invest with Confidence: Follow TipRanks'